Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy

Sara Al-Khawaga; Roopesh Krishnankutty; Gulab Sher; Khairunnisa Hussain; Joerg Buddenkotte; Martin Steinhoff

doi:10.1016/j.jdcr.2021.09.002

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy

JAAD Case Rep. 2021 Sep 8:16:164-167. doi: 10.1016/j.jdcr.2021.09.002. eCollection 2021 Oct.

Authors

Sara Al-Khawaga^{1

2}, Roopesh Krishnankutty², Gulab Sher², Khairunnisa Hussain¹, Joerg Buddenkotte^{1

2}, Martin Steinhoff^{1

2

3

4

5

6}

Affiliations

¹ Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.
² Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
³ Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
⁴ Department of Dermatology, Weill Cornell Medicine, New York, New York.
⁵ Qatar University, College of Medicine, Doha, Qatar.
⁶ Weill Cornell Medicine-Qatar, College of Medicine, Doha, Qatar.

No abstract available

Keywords: ACH, acrodermatitis continua of Hallopeau; IL, interleukin; TNF, tumor necrosis factor; certolizumab; cytokine profiling; guselkumab; proteomics; psoriasis.

Publication types

Case Reports